Literature DB >> 31124567

Longitudinal trajectories of hospital performance across targeted cardiovascular conditions in the USA.

Muthiah Vaduganathan1, Cian P McCarthy2, Colby Ayers3, Deepak L Bhatt1, Dharam J Kumbhani3, James A de Lemos3, Gregg C Fonarow4, Ambarish Pandey3.   

Abstract

AIMS: Thirty-day risk standardized readmission and mortality rates (RSRR, RSMR) are key determinants for hospital performance for cardiovascular conditions such as acute myocardial infarction (AMI) and heart failure (HF). We evaluated whether individual hospitals in the USA perform similarly for HF and AMI over time based on readmission and mortality metrics. METHODS AND
RESULTS: A total of 1950 hospitals in the USA with continuous participation in the Centers for Medicare and Medicaid Services (CMS) public reporting programme between 2010 and 2016 were identified. Latent mixture modelling was used to define performance trajectory groups. Overall, there were consistent declines in the RSMR (16.1-14.0%) and RSRR (20.3-16.6%) for AMI from 2010 to 2016. For HF, RSRR declined over time (25.1-21.7%), while there was a modest increase in RSMR (11.3-12.0%); parallel findings were observed across performance trajectory groups. The proportion of best performing centres for HF care that were also best performers for AMI care based on the 30-day RSMR and 30-day RSRR metric was 54% and 35%, respectively. Furthermore, the discordance rate between the best and worst performers for both conditions was low (<2% for both 30-day outcomes).
CONCLUSION: In the USA, despite variation in baseline hospital-level outcomes, hospitals had consistent longitudinal trajectories (worsening or improvement) across conditions and metrics. Hospitals identified as high performing were frequently similar across target conditions and over time, suggesting that performance may be driven by systems of care influencing different disease states in a comparable manner. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Heart failure; Hospital performance; Myocardial infarction; Quality

Mesh:

Year:  2020        PMID: 31124567      PMCID: PMC7828471          DOI: 10.1093/ehjqcco/qcz026

Source DB:  PubMed          Journal:  Eur Heart J Qual Care Clin Outcomes        ISSN: 2058-1742


  27 in total

1.  A roadmap for comparing readmission policies with application to Denmark, England, Germany and the United States.

Authors:  Søren Rud Kristensen; Mickael Bech; Wilm Quentin
Journal:  Health Policy       Date:  2014-12-15       Impact factor: 2.980

Review 2.  Developing evidence-based and accountable health policy in heart failure.

Authors:  Cian P McCarthy; Muthiah Vaduganathan; Ambarish Pandey
Journal:  Eur J Heart Fail       Date:  2018-10-08       Impact factor: 15.534

3.  Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines.

Authors:  Ambarish Pandey; Harsh Golwala; Hurst M Hall; Tracy Y Wang; Di Lu; Ying Xian; Karen Chiswell; Karen E Joynt; Abhinav Goyal; Sandeep R Das; Dharam Kumbhani; Howard Julien; Gregg C Fonarow; James A de Lemos
Journal:  JAMA Cardiol       Date:  2017-07-01       Impact factor: 14.676

4.  The Hospital Readmission Reduction Program Is Associated With Fewer Readmissions, More Deaths: Time to Reconsider.

Authors:  Gregg C Fonarow; Marvin A Konstam; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2017-10-10       Impact factor: 24.094

5.  Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care.

Authors:  Kori Sauser Zachrison; Deborah A Levine; Gregg C Fonarow; Deepak L Bhatt; Margueritte Cox; Phillip Schulte; Eric E Smith; Robert E Suter; Ying Xian; Lee H Schwamm
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-03

6.  Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes.

Authors:  Ambarish Pandey; Harsh Golwala; Haolin Xu; Adam D DeVore; Roland Matsouaka; Michael Pencina; Dharam J Kumbhani; Adrian F Hernandez; Deepak L Bhatt; Paul A Heidenreich; Clyde W Yancy; James A de Lemos; Gregg C Fonarow
Journal:  JACC Heart Fail       Date:  2016-12       Impact factor: 12.035

7.  Association Between Medicare Hospital Readmission Penalties and 30-Day Combined Excess Readmission and Mortality.

Authors:  Ahmad A Abdul-Aziz; Rodney A Hayward; Keith D Aaronson; Scott L Hummel
Journal:  JAMA Cardiol       Date:  2017-02-01       Impact factor: 14.676

8.  A Hospital Level Analysis of 30-Day Readmission Performance for Heart Failure Patients and Long-Term Survival: Findings from Get With The Guidelines-Heart Failure.

Authors:  Sawan Jalnapurkar; Xin Zhao; Paul A Heidenreich; Deepak L Bhatt; Eric E Smith; Adam D DeVore; Adrian F Hernandez; Roland Matsouaka; Clyde W Yancy; Gregg C Fonarow
Journal:  Am Heart J       Date:  2018-01-08       Impact factor: 4.749

9.  The economic burden of chronic cardiovascular disease for major insurers.

Authors:  Justin G Trogdon; Eric A Finkelstein; Isaac A Nwaise; Florence K Tangka; Diane Orenstein
Journal:  Health Promot Pract       Date:  2007-07

10.  Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge.

Authors:  Kumar Dharmarajan; Yongfei Wang; Zhenqiu Lin; Sharon-Lise T Normand; Joseph S Ross; Leora I Horwitz; Nihar R Desai; Lisa G Suter; Elizabeth E Drye; Susannah M Bernheim; Harlan M Krumholz
Journal:  JAMA       Date:  2017-07-18       Impact factor: 56.272

View more
  1 in total

1.  Evaluation of Risk-Adjusted Home Time After Acute Myocardial Infarction as a Novel Hospital-Level Performance Metric for Medicare Beneficiaries.

Authors:  Ambarish Pandey; Neil Keshvani; Mary S Vaughan-Sarrazin; Yubo Gao; Saket Girotra
Journal:  Circulation       Date:  2020-05-15       Impact factor: 39.918

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.